Cargando…
Healthcare Costs Associated with Complications in Patients with Type 2 Diabetes among 1.85 Million Adults in Beijing, China
We aimed to provide reliable regression estimates of expenditures associated with various complications in type 2 diabetics in China. In total, 1,859,039 type 2 diabetes patients with complications were obtained from the Beijing Medical Claim Data for Employees database from 2008 to 2016. We estimat...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036594/ https://www.ncbi.nlm.nih.gov/pubmed/33916217 http://dx.doi.org/10.3390/ijerph18073693 |
_version_ | 1783676946883805184 |
---|---|
author | Wu, Jun-Hui Wu, Yao Wang, Zi-Jing Wu, Yi-Qun Wu, Tao Wang, Meng-Ying Wang, Xiao-Wen Wang, Si-Yue Wang, Jia-Ting Yu, Huan Hu, Yong-Hua |
author_facet | Wu, Jun-Hui Wu, Yao Wang, Zi-Jing Wu, Yi-Qun Wu, Tao Wang, Meng-Ying Wang, Xiao-Wen Wang, Si-Yue Wang, Jia-Ting Yu, Huan Hu, Yong-Hua |
author_sort | Wu, Jun-Hui |
collection | PubMed |
description | We aimed to provide reliable regression estimates of expenditures associated with various complications in type 2 diabetics in China. In total, 1,859,039 type 2 diabetes patients with complications were obtained from the Beijing Medical Claim Data for Employees database from 2008 to 2016. We estimated costs for complications using a generalized estimating equation model adjusted for age, sex, and the incidence of various complications. The average total cost for diabetic patients with complications was 17.12 thousand RMB. Prescribed drugs accounted for 63.4% of costs. We observed a significant increase in costs in the first year after the onset of complications. Compared with costs before the incidence of complications, the additional costs per person in the first year and >1 year after the event would be 10,631.16 RMB and 1150.71 RMB for cardiovascular disease, 1017.62 RMB and 653.82 RMB for cerebrovascular disease, and 301.14 RMB and 624.00 RMB for kidney disease, respectively. The estimated coefficients for outpatient visits were relatively lower than those of inpatient visits. Complications in diabetics exert a significant impact on total healthcare costs in the first year of their onset and in subsequent years. Our estimates may assist policymakers in quantifying the economic burden of diabetes complications. |
format | Online Article Text |
id | pubmed-8036594 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80365942021-04-12 Healthcare Costs Associated with Complications in Patients with Type 2 Diabetes among 1.85 Million Adults in Beijing, China Wu, Jun-Hui Wu, Yao Wang, Zi-Jing Wu, Yi-Qun Wu, Tao Wang, Meng-Ying Wang, Xiao-Wen Wang, Si-Yue Wang, Jia-Ting Yu, Huan Hu, Yong-Hua Int J Environ Res Public Health Article We aimed to provide reliable regression estimates of expenditures associated with various complications in type 2 diabetics in China. In total, 1,859,039 type 2 diabetes patients with complications were obtained from the Beijing Medical Claim Data for Employees database from 2008 to 2016. We estimated costs for complications using a generalized estimating equation model adjusted for age, sex, and the incidence of various complications. The average total cost for diabetic patients with complications was 17.12 thousand RMB. Prescribed drugs accounted for 63.4% of costs. We observed a significant increase in costs in the first year after the onset of complications. Compared with costs before the incidence of complications, the additional costs per person in the first year and >1 year after the event would be 10,631.16 RMB and 1150.71 RMB for cardiovascular disease, 1017.62 RMB and 653.82 RMB for cerebrovascular disease, and 301.14 RMB and 624.00 RMB for kidney disease, respectively. The estimated coefficients for outpatient visits were relatively lower than those of inpatient visits. Complications in diabetics exert a significant impact on total healthcare costs in the first year of their onset and in subsequent years. Our estimates may assist policymakers in quantifying the economic burden of diabetes complications. MDPI 2021-04-01 /pmc/articles/PMC8036594/ /pubmed/33916217 http://dx.doi.org/10.3390/ijerph18073693 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wu, Jun-Hui Wu, Yao Wang, Zi-Jing Wu, Yi-Qun Wu, Tao Wang, Meng-Ying Wang, Xiao-Wen Wang, Si-Yue Wang, Jia-Ting Yu, Huan Hu, Yong-Hua Healthcare Costs Associated with Complications in Patients with Type 2 Diabetes among 1.85 Million Adults in Beijing, China |
title | Healthcare Costs Associated with Complications in Patients with Type 2 Diabetes among 1.85 Million Adults in Beijing, China |
title_full | Healthcare Costs Associated with Complications in Patients with Type 2 Diabetes among 1.85 Million Adults in Beijing, China |
title_fullStr | Healthcare Costs Associated with Complications in Patients with Type 2 Diabetes among 1.85 Million Adults in Beijing, China |
title_full_unstemmed | Healthcare Costs Associated with Complications in Patients with Type 2 Diabetes among 1.85 Million Adults in Beijing, China |
title_short | Healthcare Costs Associated with Complications in Patients with Type 2 Diabetes among 1.85 Million Adults in Beijing, China |
title_sort | healthcare costs associated with complications in patients with type 2 diabetes among 1.85 million adults in beijing, china |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036594/ https://www.ncbi.nlm.nih.gov/pubmed/33916217 http://dx.doi.org/10.3390/ijerph18073693 |
work_keys_str_mv | AT wujunhui healthcarecostsassociatedwithcomplicationsinpatientswithtype2diabetesamong185millionadultsinbeijingchina AT wuyao healthcarecostsassociatedwithcomplicationsinpatientswithtype2diabetesamong185millionadultsinbeijingchina AT wangzijing healthcarecostsassociatedwithcomplicationsinpatientswithtype2diabetesamong185millionadultsinbeijingchina AT wuyiqun healthcarecostsassociatedwithcomplicationsinpatientswithtype2diabetesamong185millionadultsinbeijingchina AT wutao healthcarecostsassociatedwithcomplicationsinpatientswithtype2diabetesamong185millionadultsinbeijingchina AT wangmengying healthcarecostsassociatedwithcomplicationsinpatientswithtype2diabetesamong185millionadultsinbeijingchina AT wangxiaowen healthcarecostsassociatedwithcomplicationsinpatientswithtype2diabetesamong185millionadultsinbeijingchina AT wangsiyue healthcarecostsassociatedwithcomplicationsinpatientswithtype2diabetesamong185millionadultsinbeijingchina AT wangjiating healthcarecostsassociatedwithcomplicationsinpatientswithtype2diabetesamong185millionadultsinbeijingchina AT yuhuan healthcarecostsassociatedwithcomplicationsinpatientswithtype2diabetesamong185millionadultsinbeijingchina AT huyonghua healthcarecostsassociatedwithcomplicationsinpatientswithtype2diabetesamong185millionadultsinbeijingchina |